Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT07318597 · RECRUITING

Trial details

NCT number: NCT07318597
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)

Start date: 2026-05-06
Primary completion: 2028-02-27
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.